NCT01816269

Brief Summary

Patients who had received H.pylori eradication treatment will be categorised as eradication and reinfection status and whether dental scaling has any influence on these results.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2013

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

March 20, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 22, 2013

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
Last Updated

March 22, 2013

Status Verified

March 1, 2013

Enrollment Period

2 months

First QC Date

March 20, 2013

Last Update Submit

March 21, 2013

Conditions

Keywords

Helicobacter pyloriDental scalingEradicationReinfectionHelicobacter status

Outcome Measures

Primary Outcomes (1)

  • The eradication and reinfection rates in dental scaled and non-scaled patients.

    last 1 year

Secondary Outcomes (1)

  • Reinfection rate of patients treated for H.pylori

    1 year

Study Arms (2)

Patients with scaling and patients without scaling

No drug

Helicobacter eradicated or non-eradicated

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Eligible population with H.pylori infection and result of treatment based on presence of dental scaling.

You may qualify if:

  • Patients over 18 with h.pylori positivity and received anti-Hp treatment giving informed consent to analyse of their data on this subject.

You may not qualify if:

  • Comorbidities with cardiac, liver and medical contraindication to perform dental scaling.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

GoztepeTRH

Istanbul, Istanbul, 34727, Turkey (Türkiye)

Location

GoztepeTRH

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Reinfection

Condition Hierarchy (Ancestors)

RecurrenceDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD Department of Gastroenterology

Study Record Dates

First Submitted

March 20, 2013

First Posted

March 22, 2013

Study Start

March 1, 2013

Primary Completion

May 1, 2013

Study Completion

May 1, 2013

Last Updated

March 22, 2013

Record last verified: 2013-03

Locations